Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

657
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
657
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

164
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
164
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

141
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
141
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

226
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
226
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

342
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
342

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models.

Statistics in medicine·2026
Same author

Overview and Practical Recommendations on Using Shapley Values for Identifying Predictive Biomarkers via CATE Modeling.

Statistics in medicine·2026
Same author

Evaluating Causal Effects on Time-to-Event Outcomes in an RCT in Oncology With Treatment Discontinuation.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Futility Analyses for the MCP-Mod Methodology Based on Longitudinal Models.

Statistics in medicine·2025
Same author

Randomization-Based Inference for MCP-Mod.

Statistics in medicine·2025
Same author

Closed MCP-Mod for Pairwise Comparisons of Several Doses With a Control.

Statistics in medicine·2025
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
07:38

Strategies for Assessing Autistic-Like Behaviors in Mice

Published on: September 20, 2024

2.1K

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity.

Konstantinos Sechidis1, Cong Zhang2, Sophie Sun3

  • 1Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland.

Statistics in Medicine
|November 27, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces new methods to assess treatment effect heterogeneity (TEH) in clinical trials. These methods help personalize medicine by understanding how treatments affect individual patients.

Keywords:
conditional average treatment effectheterogeneous treatment effectmachine learningmeta‐learnerssubgroup analysis

More Related Videos

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Related Experiment Videos

Last Updated: Jan 10, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
07:38

Strategies for Assessing Autistic-Like Behaviors in Mice

Published on: September 20, 2024

2.1K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Pharmacovigilance

Background:

  • Assessing treatment effect heterogeneity (TEH) is vital for drug development and personalized medicine.
  • Understanding patient variability in treatment response informs clinical decisions.
  • Existing methods may not fully capture individualized treatment effects.

Purpose of the Study:

  • To introduce novel methodologies for assessing treatment effect heterogeneity (TEH) based on individualized treatment effects.
  • To develop tools for global heterogeneity testing, covariate effect modification ranking, and individualized treatment effect estimation.
  • To integrate these methods into a robust framework for clinical trial analysis.

Main Methods:

  • Utilized a doubly robust (DR) learner to infer a pseudo-outcome reflecting causal contrast.
  • Applied the pseudo-outcome for global heterogeneity testing, covariate effect modification analysis, and individualized treatment effect estimation.
  • Compared the DR-learner with alternative methods in simulations and a pooled analysis of psoriatic arthritis (PsA) trials.

Main Results:

  • The DR-learner demonstrated robust performance in estimating individualized treatment effects and assessing heterogeneity.
  • Simulation studies validated the proposed methods' effectiveness compared to competing approaches.
  • Analysis of psoriatic arthritis (PsA) trials revealed significant insights into treatment effect heterogeneity.

Conclusions:

  • The novel DR-learner-based methodologies provide a robust framework for assessing treatment effect heterogeneity (TEH).
  • These methods enhance decision-making in drug development and facilitate personalized medicine strategies.
  • Integration with the WATCH workflow offers comprehensive TEH analysis for clinical trial sponsors.